Outlook Therapeutics Inc Stock Fundamentals
| OTLK Stock | USD 5.03 0.10 1.95% |
OUTLOOK THERAPEUTICS INC fundamentals help investors to digest information that contributes to OUTLOOK THERAPEUTICS's financial success or failures. It also enables traders to predict the movement of OUTLOOK Stock. The fundamental analysis module provides a way to measure OUTLOOK THERAPEUTICS's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to OUTLOOK THERAPEUTICS stock.
At this time, OUTLOOK THERAPEUTICS's Interest Expense is quite stable compared to the past year. Research Development is expected to rise to about 31.5 M this year, although the value of Gross Profit is projected to rise to (37.8 K). OUTLOOK | Select Account or Indicator |
OUTLOOK THERAPEUTICS INC Company Return On Equity Analysis
OUTLOOK THERAPEUTICS's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current OUTLOOK THERAPEUTICS Return On Equity | -0.0365 |
Most of OUTLOOK THERAPEUTICS's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, OUTLOOK THERAPEUTICS INC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
OUTLOOK Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, OUTLOOK THERAPEUTICS INC has a Return On Equity of -0.0365. This is 99.85% lower than that of the Biotechnology sector and 99.9% lower than that of the Health Care industry. The return on equity for all United States stocks is 88.23% lower than that of the firm.
OUTLOOK THERAPEUTICS INC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining OUTLOOK THERAPEUTICS's current stock value. Our valuation model uses many indicators to compare OUTLOOK THERAPEUTICS value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across OUTLOOK THERAPEUTICS competition to find correlations between indicators driving OUTLOOK THERAPEUTICS's intrinsic value. More Info.OUTLOOK THERAPEUTICS INC is regarded second in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, OUTLOOK THERAPEUTICS's Return On Equity is quite stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value OUTLOOK THERAPEUTICS by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.OUTLOOK Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses OUTLOOK THERAPEUTICS's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of OUTLOOK THERAPEUTICS could also be used in its relative valuation, which is a method of valuing OUTLOOK THERAPEUTICS by comparing valuation metrics of similar companies.OUTLOOK THERAPEUTICS is currently under evaluation in return on equity category among its peers.
OUTLOOK THERAPEUTICS Current Valuation Drivers
We derive many important indicators used in calculating different scores of OUTLOOK THERAPEUTICS from analyzing OUTLOOK THERAPEUTICS's financial statements. These drivers represent accounts that assess OUTLOOK THERAPEUTICS's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of OUTLOOK THERAPEUTICS's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 52.2M | 331.3M | 258.7M | 55.3M | 49.8M | 91.1M | |
| Enterprise Value | 48.5M | 328.7M | 252.3M | 67.5M | 60.7M | 97.1M |
OUTLOOK THERAPEUTICS ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, OUTLOOK THERAPEUTICS's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to OUTLOOK THERAPEUTICS's managers, analysts, and investors.Environmental | Governance | Social |
OUTLOOK Fundamentals
| Return On Equity | -0.0365 | ||||
| Return On Asset | -0.84 | ||||
| Current Valuation | 119.69 M | ||||
| Shares Outstanding | 23.66 M | ||||
| Shares Owned By Insiders | 35.58 % | ||||
| Shares Owned By Institutions | 35.64 % | ||||
| Number Of Shares Shorted | 3.23 M | ||||
| Price To Earning | (1.24) X | ||||
| Price To Book | 10.19 X | ||||
| Price To Sales | 13.27 X | ||||
| Gross Profit | (42.33 M) | ||||
| EBITDA | (57.38 M) | ||||
| Net Income | (58.98 M) | ||||
| Cash And Equivalents | 26.02 M | ||||
| Cash Per Share | 0.12 X | ||||
| Total Debt | 35.56 M | ||||
| Debt To Equity | 0.52 % | ||||
| Current Ratio | 2.04 X | ||||
| Book Value Per Share | (3.58) X | ||||
| Cash Flow From Operations | (42.97 M) | ||||
| Short Ratio | 12.33 X | ||||
| Earnings Per Share | (5.89) X | ||||
| Target Price | 39.5 | ||||
| Number Of Employees | 24 | ||||
| Beta | 0.63 | ||||
| Market Capitalization | 118.99 M | ||||
| Total Asset | 32.3 M | ||||
| Retained Earnings | (467.92 M) | ||||
| Working Capital | (15.75 M) | ||||
| Current Asset | 4.12 M | ||||
| Current Liabilities | 28.27 M | ||||
| Net Asset | 32.3 M |
About OUTLOOK THERAPEUTICS Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze OUTLOOK THERAPEUTICS INC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of OUTLOOK THERAPEUTICS using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of OUTLOOK THERAPEUTICS INC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 2.1 M | 2.1 M | |
| Cost Of Revenue | 50.8 K | 48.3 K | |
| Stock Based Compensation To Revenue | 0.19 | 0.18 | |
| Sales General And Administrative To Revenue | 1.04 | 0.98 | |
| Research And Ddevelopement To Revenue | 3.36 | 6.45 | |
| Capex To Revenue | 0.06 | 0.06 | |
| Revenue Per Share | 10.30 | 9.78 | |
| Ebit Per Revenue | (5.12) | (5.38) |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out OUTLOOK THERAPEUTICS Piotroski F Score and OUTLOOK THERAPEUTICS Altman Z Score analysis. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OUTLOOK THERAPEUTICS. If investors know OUTLOOK will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OUTLOOK THERAPEUTICS listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.89) | Revenue Per Share 0.119 | Quarterly Revenue Growth 6.583 | Return On Assets (0.84) | Return On Equity (0.04) |
The market value of OUTLOOK THERAPEUTICS INC is measured differently than its book value, which is the value of OUTLOOK that is recorded on the company's balance sheet. Investors also form their own opinion of OUTLOOK THERAPEUTICS's value that differs from its market value or its book value, called intrinsic value, which is OUTLOOK THERAPEUTICS's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OUTLOOK THERAPEUTICS's market value can be influenced by many factors that don't directly affect OUTLOOK THERAPEUTICS's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OUTLOOK THERAPEUTICS's value and its price as these two are different measures arrived at by different means. Investors typically determine if OUTLOOK THERAPEUTICS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OUTLOOK THERAPEUTICS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.